RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Showing results 1 to 20 of 22.

News Release

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

August 14, 2019
RTI In The Media

Doris Rouse's Lifelong Journey to Save Those Suffering from Tuberculosis

November 08, 2019 - Triangle Business Journal
RTI In The Media

Cannabis Doesn’t Enhance Performance. So Why Is It Banned in Elite Sports?

November 09, 2021 - PBS
RTI In The Media

FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB

August 15, 2019 - Medscape
Expert

Archana Krovi

News Release

NCCU and RTI celebrate new partnership and shared lab space supporting health and environmental justice research

May 04, 2022
RTI In The Media

RTP-Based APIE Therapeutics, RTI Team Up to Develop Drug for Rare Lung Disease

August 26, 2020 - WRAL TechWire
News Release

RTI International Licenses Portfolio of Compounds to APIE Therapeutics

August 25, 2020
RTI In The Media

‘More Power in Knowing’: PFAS Health Study Under Way in Montgomery, Bucks Counties

December 14, 2021 - WHYY
Expert

Sara Maloney Norcross

RTI In The Media

Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators

August 14, 2019 - The Telegraph
RTI In The Media

Breakthrough in Fight Against Multi-Resistant Tuberculosis

September 02, 2019 - Forbes
RTI In The Media

Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators

August 15, 2019 - Yahoo News UK
RTI In The Media

Landmark Study Highlights Promising PTSD Treatment

January 21, 2020 - WUNC
Impact

Senna Side Effects: Measuring Chemicals in a Botanical Dietary Supplement

June 08, 2021
RTI In The Media

Ep 41: Bruce Blough, Elliott Pauli & CC4CARB

September 05, 2022 - The AMR Studio Podcast
RTI In The Media

After 20 Years of Research, RTI Drug Approved for Drug-Resistant Tuberculosis

August 14, 2019 - Triangle Business Journal
Announcement

New Paper Describes Accurate, Scalable Method for Detecting Fragile X Syndrome in Newborns

March 05, 2020
RTI In The Media

How K2 and Other Synthetic Cannabinoids Got Their Start

November 28, 2018 - The Scientist
Announcement

RTI Secures Chemistry Center for Combating Antibiotic Resistance (CC4CARB) Contract from National Institute of Allergy and Infectious Diseases to Address Bottlenecks in Early Antibiotic Drug Discovery

April 16, 2021